These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3253190)
1. Pharmaceutical products and government policies. Fernandez ST Indian J Ophthalmol; 1988; 36(1):1-2. PubMed ID: 3253190 [No Abstract] [Full Text] [Related]
2. [Is openness in the drug market possible?]. Dölle W; Schwabe U Internist (Berl); 1986 Jan; 27(1):21-31. PubMed ID: 3514513 [No Abstract] [Full Text] [Related]
3. Drug quality control work in Daru: observations during 1983-1986. Kibwage IO; Ogeto JO; Maitai CK; Rutere G; Thuranira J; Ochieng' A East Afr Med J; 1992 Oct; 69(10):577-80. PubMed ID: 1473513 [TBL] [Abstract][Full Text] [Related]
4. 3. Drug regulations in Switzerland and their application. Hippenmeier F Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448 [No Abstract] [Full Text] [Related]
5. [Legal basis and significance of manufacturing control in Switzerland]. Fischer P Pharm Acta Helv; 1972; 47(11):629-36. PubMed ID: 4657532 [No Abstract] [Full Text] [Related]
6. Rationale drug therapy: reasons for failure and suggestions for its implementation. Mathur GP; Kushwaha KP; Mathur S Indian Pediatr; 1993 Jun; 30(6):815-8. PubMed ID: 7726879 [No Abstract] [Full Text] [Related]
7. [Responsibility for drug testing and control]. Büchi J Pharm Acta Helv; 1968 Sep; 43(9):619-27. PubMed ID: 5718866 [No Abstract] [Full Text] [Related]
8. Validation--how much can the world afford? Are we getting value for money? Anisfeld MH J Pharm Sci Technol; 1994; 48(1):45-8. PubMed ID: 8004419 [TBL] [Abstract][Full Text] [Related]
9. [An analysis of the pharmaceuticals market in Vietnam]. Simonet D Sante; 2001; 11(3):155-60. PubMed ID: 11641078 [TBL] [Abstract][Full Text] [Related]
10. The role of the federal government in the development of narcotic antagonists. Green AI Adv Biochem Psychopharmacol; 1973; 8(0):576-7. PubMed ID: 4795123 [No Abstract] [Full Text] [Related]
11. Veterinary drug availability. Gloyd J J Am Vet Med Assoc; 1980 Apr; 176(7):611-4. PubMed ID: 7372533 [No Abstract] [Full Text] [Related]
12. Relative efficacy. When the government decides what drugs should be prescribed, is the patient better served? Ohio State Med J; 1972 Aug; 68(8):748-52 passim. PubMed ID: 5077306 [No Abstract] [Full Text] [Related]
13. [Quality control in the pharmaceutical industry]. Sloot HA Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061 [No Abstract] [Full Text] [Related]
14. Remarks at the Food and Drug Law Institute's 48th Annual Conference. Niedelman SM Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089 [No Abstract] [Full Text] [Related]
15. Editorial: drug scandal. Mukerjee AB J Indian Med Assoc; 1974 May; 62(9):326-8. PubMed ID: 4436552 [No Abstract] [Full Text] [Related]
16. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573 [TBL] [Abstract][Full Text] [Related]
17. Drug regulation and policy formulation. Nightingale SL Milbank Mem Fund Q Health Soc; 1981; 59(3):412-44. PubMed ID: 7024847 [TBL] [Abstract][Full Text] [Related]
18. Multisource drug policies in Latin America: survey of 10 countries. Homedes N; Ugalde A Bull World Health Organ; 2005 Jan; 83(1):64-70. PubMed ID: 15682251 [TBL] [Abstract][Full Text] [Related]
19. Drugs and the Washington climate. Durant TM Trans Am Clin Climatol Assoc; 1969; 80():196-204. PubMed ID: 4896316 [No Abstract] [Full Text] [Related]